Health
Could Galectin-3 be a potential biomarker to help identify severe COVID-19 early? – News-Medical.Net
Researchers have measured the galectin-3 levels in the sera of hospitalized patients. They found initial high levels indicate patients will become severely ill,…
Researchers have measured the galectin-3 levels in the sera of hospitalized patients with coronavirus disease 2019 (COVID-19). They found initial high levels indicate patients will become severely ill, suggesting it could be used as a predictor of severe disease.
As the COVID-19 pandemic continues to claim more lives, with many patients becoming severely ill, biomarkers that can predict disease severity will help better treat such patients. Patients with severe disease show a hyperinflammatory response…
-
Noosa News14 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Business15 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General22 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
General21 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz